Genetic Analysis AS (XSAT:GEAN)
0.8050
-0.0350 (-4.17%)
At close: Aug 15, 2025
Genetic Analysis AS Revenue
Genetic Analysis AS had revenue of 4.01M NOK in the quarter ending March 31, 2025, a decrease of -15.88%. This brings the company's revenue in the last twelve months to 19.93M, down -7.64% year-over-year. In the year 2024, Genetic Analysis AS had annual revenue of 20.68M, down -10.71%.
Revenue (ttm)
19.93M NOK
Revenue Growth
-7.64%
P/S Ratio
2.74
Revenue / Employee
1.25M NOK
Employees
16
Market Cap
52.17M SEK
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.68M | -2.48M | -10.71% |
Dec 31, 2023 | 23.16M | 2.42M | 11.65% |
Dec 31, 2022 | 20.75M | 7.37M | 55.08% |
Dec 31, 2021 | 13.38M | 5.84M | 77.51% |
Dec 31, 2020 | 7.54M | -3.52M | -31.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Investor AB | 85.17B |
Atlas Copco AB | 173.03B |
AB Volvo | 500.08B |
EQT AB | 30.08B |
ASSA ABLOY AB | 152.95B |
Skandinaviska Enskilda Banken AB | 78.55B |
Swedbank AB | 72.19B |
Sandvik AB | 121.46B |